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The “plus” side of epilepsy phenotyping
The first clinical description of generalized epilepsy
with febrile seizures plus (GEFS1) by Scheffer and
Berkovic1 in their landmark Brain article of 1997
represented a major step forward in the understand-
ing of the genetic basis of the epilepsies. Coming
2 years after their identification, with collaborators,
of the genetic basis for a relatively homogenous syn-
drome, autosomal dominant nocturnal frontal lobe
epilepsy, the detailed phenotypic description of a sin-
gle large Australian family with heterogeneous febrile
seizure plus epilepsy phenotypes and a clear dominant
pattern of inheritance put a novel perspective on
genotype–phenotype relationships in the epilepsies.2
Shortly after, the SCN1A and SCN1B genes were
linked to the syndrome, and subsequently the last
2 decades has confirmed that the majority of epilepsy
genes show phenotypic heterogeneity and the
majority of syndromes reveal genetic heterogeneity.3
Why one individual in a GEFS1 family has a severe
developmental and epileptic encephalopathy such as
Dravet syndrome and another has simple self-limited
febrile seizures is unknown, but is likely to be deter-
mined by other genetic factors influencing the
SCN1A, or other major genes identified in a family.
Twenty years later, the Melbourne group has re-
visited GEFS1 and further refined the classification
and boundaries of this relatively common familial
epilepsy syndrome. In this issue ofNeurology®, Zhang
et al.4 analyzed the phenotypic spectrum in over 400
affected individuals in 60 (31 previously unreported)
families. Clinical information was obtained from pa-
rents, spouses, or other eyewitnesses using a validated
seizure questionnaire. Previous medical records were
reviewed, including EEG, video-EEG monitoring,
and MRI studies. Blood samples and genetic analysis
was performed in the probands and family members
where possible. Then the authors performed detailed
electroclinical phenotyping on available affected fam-
ilies and compared their phenotypic and genetic data
to those published in the literature over the last
19 years. By doing so, they have expanded the
GEFS1 spectrum and identified new phenotypes,
namely focal seizures without preceding febrile
seizures and classic genetic generalized epilepsies.
As about 9% of affected individuals have focal epilep-
sies, the authors suggest that GEFS1 be renamed
genetic epilepsy with febrile seizures plus. This
change in terminology is already widely accepted fol-
lowing several articles reporting focal seizures and
epilepsies in GEFS1 families.5,6 In addition, the phe-
notypic overlap between GEFS1 and the classic
generalized epilepsies is considerably greater than pre-
viously reported. The authors coin the term early-
onset genetic generalized epilepsies for a small subset
of patients. Whether this term has clinical and
research utility will require further validation.
In their study, the authors report genetic variants
in 11/31 GEFS1 families. SCN1A was reported in
3 families and the relevance of some of the other
variants, notably SCN9A, in terms of pathogenicity
in GEFS1 remains debatable. The report of SCN8A
and PRRT2 is worthy of scrutiny. The PRRT2 var-
iants segregate with self-limited infantile seizures in
this family and are not seen with other phenotypes.
The SCN8A variant segregates within a family to
a child with a severe SCN8A developmental and epi-
leptic encephalopathy and to a mosaic father.
The 2017 International League Against Epilepsy
Classification of Seizure Types and the Epilepsies re-
flects scientific advances over the last 3 decades by
incorporating an etiologic classification alongside
the electroclinical phenotype.7,8 This approach
focuses the clinician on stratifying treatment when
possible based on etiology. Well-described epilepsy
syndromes, such as Ohtahara and Lennox-Gastaut
syndromes, which had established electroclinical phe-
notypes, are now regarded as of diminished clinical
utility unless they are also classified by their structural
or genetic etiology. Zhang et al. present a large house
for GEFS1 and it is likely that to define prognosis for
the individual and aid genetic counseling, detailed
genetic classification will be needed alongside preci-
sion phenotyping; at present, this is only possible for
a minority of GEFS1 cases. This article is an impor-
tant addition to the literature, providing clarification
on several details of the phenotypic spectrum and
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raising more questions about the role and relevance of
genetic heterogeneity.
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